156 related articles for article (PubMed ID: 15954537)
1. Comparison of protective effect of protein and DNA vaccines hsp90 in murine model of systemic candidiasis.
Raska M; Beláková J; Wudattu NK; Kafková L; Růzicková K; Sebestová M; Kolár Z; Weigl E
Folia Microbiol (Praha); 2005; 50(1):77-82. PubMed ID: 15954537
[TBL] [Abstract][Full Text] [Related]
2. Systemic and mucosal immunization with Candida albicans hsp90 elicits hsp90-specific humoral response in vaginal mucosa which is further enhanced during experimental vaginal candidiasis.
Raska M; Belakova J; Horynova M; Krupka M; Novotny J; Sebestova M; Weigl E
Med Mycol; 2008 Aug; 46(5):411-20. PubMed ID: 18608941
[TBL] [Abstract][Full Text] [Related]
3. Vaccination with Secreted Aspartyl Proteinase 2 Protein from
Shukla M; Rohatgi S
Infect Immun; 2020 Sep; 88(10):. PubMed ID: 32661125
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant effect of polysaccharide from fruits of Physalis alkekengi L. in DNA vaccine against systemic candidiasis.
Yang H; Han S; Zhao D; Wang G
Carbohydr Polym; 2014 Aug; 109():77-84. PubMed ID: 24815404
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of fungal extracellular vesicles against murine candidiasis.
Vargas G; Honorato L; Guimarães AJ; Rodrigues ML; Reis FCG; Vale AM; Ray A; Nosanchuk JD; Nimrichter L
Cell Microbiol; 2020 Oct; 22(10):e13238. PubMed ID: 32558196
[TBL] [Abstract][Full Text] [Related]
6. Hybrid phage displaying SLAQVKYTSASSI induces protection against Candida albicans challenge in BALB/c mice.
Wang Y; Su Q; Dong S; Shi H; Gao X; Wang L
Hum Vaccin Immunother; 2014; 10(4):1057-63. PubMed ID: 24448202
[TBL] [Abstract][Full Text] [Related]
7. Immunisation with the glycolytic enzyme enolase confers effective protection against Candida albicans infection in mice.
Li Wq; Hu Xc; Zhang X; Ge Y; Zhao S; Hu Y; Ashman RB
Vaccine; 2011 Jul; 29(33):5526-33. PubMed ID: 21645574
[TBL] [Abstract][Full Text] [Related]
8. Active immunizations with peptide-DC vaccines and passive transfer with antibodies protect neutropenic mice against disseminated candidiasis.
Xin H
Vaccine; 2016 Jan; 34(2):245-251. PubMed ID: 26620842
[TBL] [Abstract][Full Text] [Related]
9. NDV-3 protects mice from vulvovaginal candidiasis through T- and B-cell immune response.
Ibrahim AS; Luo G; Gebremariam T; Lee H; Schmidt CS; Hennessey JP; French SW; Yeaman MR; Filler SG; Edwards JE
Vaccine; 2013 Nov; 31(47):5549-56. PubMed ID: 24063977
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of a vaccine composed of heat-killed Candida albicans and a novel mucosal adjuvant, LT(R192G), against systemic candidiasis.
Cárdenas-Freytag L; Cheng E; Mayeux P; Domer JE; Clements JD
Infect Immun; 1999 Feb; 67(2):826-33. PubMed ID: 9916097
[TBL] [Abstract][Full Text] [Related]
11. Ginsenoside Rd induces protective anti-Candida albicans antibody through immunological adjuvant activity.
Han Y; Rhew KY
Int Immunopharmacol; 2013 Nov; 17(3):651-7. PubMed ID: 24007781
[TBL] [Abstract][Full Text] [Related]
12. Adjuvanticity of a recombinant calreticulin fragment in assisting anti-β-glucan IgG responses in T cell-deficient mice.
Li WJ; Long K; Dong HL; Gao XM
Clin Vaccine Immunol; 2013 Apr; 20(4):582-9. PubMed ID: 23408527
[TBL] [Abstract][Full Text] [Related]
13. The anti-Candida albicans vaccine composed of the recombinant N terminus of Als1p reduces fungal burden and improves survival in both immunocompetent and immunocompromised mice.
Spellberg BJ; Ibrahim AS; Avenissian V; Filler SG; Myers CL; Fu Y; Edwards JE
Infect Immun; 2005 Sep; 73(9):6191-3. PubMed ID: 16113347
[TBL] [Abstract][Full Text] [Related]
14. Candida albicans mannan extract-protein conjugates induce a protective immune response against experimental candidiasis.
Han Y; Ulrich MA; Cutler JE
J Infect Dis; 1999 Jun; 179(6):1477-84. PubMed ID: 10228070
[TBL] [Abstract][Full Text] [Related]
15. Chitosan hydrogel loaded with recombinant protein containing epitope C from HSP90 of Candida albicans induces protective immune responses against systemic candidiasis.
Li X; Yang Y; Yang F; Wang F; Li H; Tian H; Wang G
Int J Biol Macromol; 2021 Mar; 173():327-340. PubMed ID: 33482211
[TBL] [Abstract][Full Text] [Related]
16. Comparison of two Candida mannan vaccines: the role of complement in protection against disseminated candidiasis.
Han Y; Rhew KY
Arch Pharm Res; 2012 Nov; 35(11):2021-7. PubMed ID: 23212645
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic vaccination with phage-displayed epitope of C. albicans elicits protective immune responses against systemic candidiasis in C57BL/6 mice.
Yang Q; Wang L; Lu DN; Gao RJ; Song JN; Hua PY; Yuan DW
Vaccine; 2005 Jul; 23(31):4088-96. PubMed ID: 15963364
[TBL] [Abstract][Full Text] [Related]
18. Design of a mimotope-peptide based double epitope vaccine against disseminated candidiasis.
Xin H; Glee P; Adams A; Mohiuddin F; Eberle K
Vaccine; 2019 Apr; 37(18):2430-2438. PubMed ID: 30930005
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of a genetically engineered Candida albicans tet-NRG1 strain as an experimental live attenuated vaccine against hematogenously disseminated candidiasis.
Saville SP; Lazzell AL; Chaturvedi AK; Monteagudo C; Lopez-Ribot JL
Clin Vaccine Immunol; 2009 Mar; 16(3):430-2. PubMed ID: 19144791
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Mdh1 protein as an antigenic candidate for a vaccine against candidiasis.
Shibasaki S; Aoki W; Nomura T; Karasaki M; Sewaki T; Ueda M
Biocontrol Sci; 2014; 19(1):51-5. PubMed ID: 24670619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
